Caira Mino R
Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa.
Mol Pharm. 2007 May-Jun;4(3):310-6. doi: 10.1021/mp070003j. Epub 2007 May 4.
A review of several aspects of cocrystallization involving sulfonamide drugs is presented, with a focus on other drug molecules as cocrystallization partners. Some earlier exploratory studies outlined here led to more recent systematic investigation of processes such as cocrystal preparation by solid-state cogrinding of individual components, selective cocrystal formation in competition experiments, and exchange reactions. These are discussed with reference to the drug sulfadimidine, which featured prominently as a model cocrystal former. Apart from their potential as medicinal agents, cocrystals and salts of sulfa drugs frequently display multiple related physicochemical phenomena including polymorphism, crystal isostructurality, and solvate formation, justifying past and current interest in their solid-state chemistry.
本文综述了涉及磺胺类药物共结晶的几个方面,重点关注作为共结晶伙伴的其他药物分子。这里概述的一些早期探索性研究促成了对诸如通过单个组分的固态共研磨制备共晶体、竞争实验中的选择性共晶体形成以及交换反应等过程的更近期的系统研究。这些研究结合磺胺二甲嘧啶进行了讨论,磺胺二甲嘧啶是一种典型的共晶体形成药物。除了作为药物的潜力外,磺胺类药物的共晶体和盐类经常表现出多种相关的物理化学现象,包括多晶型性、晶体同构性和溶剂化物形成,这证明了过去和当前对其固态化学感兴趣的合理性。